What is NAGE's pharmaceuticals segment — cost of sales?

NAGE (NAGE) reported pharmaceuticals segment — cost of sales of $0 in Q1 2026.

What does pharmaceuticals segment — cost of sales mean?

Includes the direct costs attributable to the production and manufacturing of pharmaceutical goods sold by the segment. This typically encompasses raw materials, direct labor, and manufacturing overheads. Monitoring this metric is essential for assessing the segment's production efficiency and cost management capabilities.

NAGE NAGE Pharmaceuticals segment — Cost of Sales

Other segment segments

Consumer Products segment

$7.6M+2.5%

Ingredients segment

$3.56M+14.6%

Analytical Reference Standards and Services segment

$308K-52.0%

Similar metrics at other companies

BAXPharmaceuticals — Cost of Sales

$458M+15.7%

ATRPharma — Cost of Sales (exclusive of depreciation and amortization):

$228.54M+11.4%

INDVReportable Segment — Cost of Sales

$40M-9.1%

FTKProducts — Cost of Sales

$48.7M+27.4%

MIRMCost of Sales

$28.81M+25.1%

BLCOPharmaceuticals — Selling, general and administrative (Note 4)

$138M-9.8%

Other financials

Income statement

See full

Revenue$31.5M+3.3%

Gross profit$20.0M+3.3%

Operating income$1.6M-67.0%

Net income$6.3M+24.8%

EPS (diluted)$0.07+16.7%

Balance sheet

See full

Cash & equivalents$66.5M+19.7%

Total debt$2.6M-26.9%

Total equity$82.3M+48.8%

Total assets$114.3M+40.6%

Cash flow

See full

Operating cash flow-$1.2M-115%

Valuation

See full

Market cap$254.07M-74.9%

Enterprise value$190.09M-79.7%

P/E13.6×-43.5×

P/S2×-6.8×

Profitability

See full

Gross margin64.3%+1.8pp

Operating margin10%-2.2pp

Net margin14.3%+1.2pp

FCF margin-70.4%—

Returns & leverage

See full

Return on equity27.1%-6.4pp

Debt / equity0×0.0×

Current ratio4.6×+0.9×

Where this comes from

Reported directly by NAGE in its filing.

Tagged under the XBRL concept us-gaap:CostOfRevenue.

The official record: NAGE’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about NAGE's pharmaceuticals segment — cost of sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NAGE's pharmaceuticals segment — cost of sales?: NAGE (NAGE) reported pharmaceuticals segment — cost of sales of $0 in Q1 2026.
What does pharmaceuticals segment — cost of sales mean?: Includes the direct costs attributable to the production and manufacturing of pharmaceutical goods sold by the segment. This typically encompasses raw materials, direct labor, and manufacturing overheads. Monitoring this metric is essential for assessing the segment's production efficiency and cost management capabilities.